SCHEMBL993574

SCHEMBL993574

CC(C)(C(=O)O)c1ccc(CCCl)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.47
SLC13A5 Q86YT5 2/20 0.44
ESRRG P62508 1/20 0.41
PPARA Q07869 2/20 0.40
LTB4R Q15722 2/20 0.40
LTB4R2 Q9NPC1 2/20 0.40
ALDH1A1 P00352 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
NR1H4 Q96RI1 2/20 0.38
EPHX2 P34913 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
MAP4K4 O95819 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11439832 0.85 HRH3 (0.49) HRH3SLC13A5ESRRGPPARAALDH1A1
SCHEMBL10975329 0.85 CA1 (0.44) HRH3SLC13A5PPARALTB4RLTB4R2
SCHEMBL992215 0.83 PPARA (0.57) HRH3SLC13A5ESRRGPPARARXRA
SCHEMBL28340064 0.81 PPARA (0.56) HRH3SLC13A5ESRRGPPARARXRA
SCHEMBL21629639 0.81 BRS3 (0.53) ESRRGALDH1A1NR1H4EPHX2NPC1
SCHEMBL28533875 0.81 SLC13A5 (0.41) SLC13A5ESRRGPPARAALDH1A1RXRA
Hydrochloric Acid SCHEMBL11112027 0.80 TAAR1 (0.48) HRH3SLC13A5ESRRGALDH1A1MAPT
SCHEMBL8587467 0.80 ALDH1A1 (0.58) HRH3ALDH1A1NPC1RAB9AMAPT
SCHEMBL19941943 0.80 ESRRG (0.40) SLC13A5ESRRGPPARAALDH1A1RXRA
SCHEMBL3669281 0.80 TDP1 (0.41) HRH3SLC13A5ESRRGLTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018042305-A1 IMPROVED PROCESSES FOR PREPARATION OF BILASTINE USING NOVEL INTERMEDIATES SYMED LABS LIMITED (IN) 2018-03-08 WO claimed
US-20250129039-A1 NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2025-04-24 US disclosed
WO-2023037184-A2 NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) 2023-03-16 WO disclosed
CN-112521267-A Preparation method of bilastine key intermediate 北京万全德众医药生物技术有限公司 2021-03-19 CN disclosed
CN-112521267-A Preparation method of bilastine key intermediate 北京万全德众医药生物技术有限公司 2021-03-19 CN disclosed
WO-2018042305-A1 IMPROVED PROCESSES FOR PREPARATION OF BILASTINE USING NOVEL INTERMEDIATES SYMED LABS LIMITED (IN) 2018-03-08 WO disclosed
WO-2018042305-A1 IMPROVED PROCESSES FOR PREPARATION OF BILASTINE USING NOVEL INTERMEDIATES SYMED LABS LIMITED (IN) 2018-03-08 WO disclosed
CN-107365298-A A kind of preparation method of the benzyl propionate derivant of 2 methyl 2 ' 罗欣生物科技(上海)有限公司 2017-11-21 CN disclosed
US-8633223-B2 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds YUHAN CORPORATION (KR) 2014-01-21 US disclosed
US-8487106-B2 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds YUHAN CORPORATION (KR) 2013-07-16 US disclosed
US-20130116439-A1 PROCESS FOR PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS YUHAN CORPORATION (KR) 2013-05-09 US disclosed
US-20130116466-A1 PROCESS FOR PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS YUHAN CORPORATION (KR) 2013-05-09 US disclosed
US-8367704-B2 Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds YUHAN CORPORATION (KR) 2013-02-05 US disclosed
US-20110009636-A1 PROCESS FOR THE PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS YUHAN CORPORATION (KP) 2011-01-13 US disclosed
EP-2240464-A2 PROCESS FOR PREPARATION OF 2-METHYL-2´-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS Yuhan Corporation (KR) 2010-10-20 EP disclosed
WO-2009102155-A2 PROCESS FOR PREPARATION OF 2-METHYL-2´-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS YUHAN CORPORATION (KR) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009636-A1 PROCESS FOR THE PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS HRH4, HCAR2, HRH1 HRH3 7/4885SLC13A5 526/4885ESRRG 4785/4885
US-20130116439-A1 PROCESS FOR PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS HRH2, HRH4, HNMT HRH3 5/4885SLC13A5 1247/4885ESRRG 4802/4885
US-20130116466-A1 PROCESS FOR PREPARATION OF 2-METHYL-2'-PHENYLPROPIONIC ACID DERIVATIVES AND NOVEL INTERMEDIATE COMPOUNDS HRH1, HRH2, HRH4 HRH3 6/4885SLC13A5 667/4885ESRRG 4732/4885
US-20250129039-A1 NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF CYP4B1, CYP3A4, CYP7A1 HRH3 22/4885SLC13A5 2208/4885ESRRG 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.